<?xml version="1.0" encoding="UTF-8"?>
<p>After the procedures of purification and characterization and the in silico analysis of drug-likeness, all the compounds (
 <bold>1</bold>â€“
 <bold>39</bold>) were tested in vitro against 
 <italic>H. pylori</italic> growth and the 12 most promising ones also against AGS cells to suggest dual-action agents useful for the treatment of 
 <italic>H. pylori</italic>-related gastric cancer development.
</p>
